v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Senior Notes Due 2030
Common Stock
Common Stock
Convertible Senior Notes Due 2030
Additional Paid-in Capital
Additional Paid-in Capital
Convertible Senior Notes Due 2030
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024     76,065,969          
Beginning balance at Dec. 31, 2024 $ (601,208)   $ 8   $ 644,004   $ (1,241,531) $ (3,689)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (61,087)           (61,087)  
Issuance of common stock under equity incentive plans, net (in shares)     342,908          
Issuance of common stock under equity incentive plans, net (220)       (220)      
Share-based compensation for equity classified awards 5,853       5,853      
Foreign currency translation adjustment (1,040)             (1,040)
Ending balance (in shares) at Mar. 29, 2025     76,408,877          
Ending balance at Mar. 29, 2025 (657,702)   $ 8   649,637   (1,302,618) (4,729)
Beginning balance (in shares) at Dec. 31, 2024     76,065,969          
Beginning balance at Dec. 31, 2024 (601,208)   $ 8   644,004   (1,241,531) (3,689)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (92,931)              
Foreign currency translation adjustment 3,508              
Reclassification of foreign currency translation to net income (loss), net of tax 0              
Ending balance (in shares) at Jun. 28, 2025     76,597,624          
Ending balance at Jun. 28, 2025 (687,797)   $ 8   653,855   (1,334,463) (7,197)
Beginning balance (in shares) at Mar. 29, 2025     76,408,877          
Beginning balance at Mar. 29, 2025 (657,702)   $ 8   649,637   (1,302,618) (4,729)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (31,845)           (31,845)  
Issuance of common stock under equity incentive plans, net (in shares)     188,747          
Issuance of common stock under equity incentive plans, net (86)       (86)      
Share-based compensation for equity classified awards 4,304       4,304      
Foreign currency translation adjustment (2,468)             (2,468)
Foreign currency translation adjustment 2,468              
Reclassification of foreign currency translation to net income (loss), net of tax 0              
Ending balance (in shares) at Jun. 28, 2025     76,597,624          
Ending balance at Jun. 28, 2025 (687,797)   $ 8   653,855   (1,334,463) (7,197)
Beginning balance (in shares) at Dec. 31, 2025     453,688,312          
Beginning balance at Dec. 31, 2025 (997)   $ 45   1,029,308   (1,022,507) (7,843)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (28,482)           (28,482)  
Issuance of common stock under equity incentive plans, net (in shares)     4,190,897          
Issuance of common stock under equity incentive plans, net (2,728)       (2,728)      
Share-based compensation for equity classified awards 6,521       6,521      
Issuance of common stock in conjunction with the conversion of a portion of 2030 Notes (in shares)       5,315,857        
Issuance of common stock in conjunction with the conversion of a portion of the 2030 Notes   $ 4,220   $ 1   $ 4,219    
Foreign currency translation adjustment 383             383
Ending balance (in shares) at Mar. 28, 2026     463,195,066          
Ending balance at Mar. 28, 2026 (21,083)   $ 46   1,037,320   (1,050,989) (7,460)
Beginning balance (in shares) at Dec. 31, 2025     453,688,312          
Beginning balance at Dec. 31, 2025 (997)   $ 45   1,029,308   (1,022,507) (7,843)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (12,078)              
Foreign currency translation adjustment (2,169)              
Reclassification of foreign currency translation to net income (loss), net of tax 894              
Ending balance (in shares) at Jun. 27, 2026     515,793,219          
Ending balance at Jun. 27, 2026 56,757   $ 52   1,096,070   (1,034,585) (4,780)
Beginning balance (in shares) at Mar. 28, 2026     463,195,066          
Beginning balance at Mar. 28, 2026 (21,083)   $ 46   1,037,320   (1,050,989) (7,460)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 16,404           16,404  
Issuance of common stock under equity incentive plans, net (in shares)     505,869          
Issuance of common stock under equity incentive plans, net (278)       (278)      
Share-based compensation for equity classified awards 7,399       7,399      
Issuance of common stock in conjunction with the conversion of a portion of 2030 Notes (in shares)       52,092,284        
Issuance of common stock in conjunction with the conversion of a portion of the 2030 Notes   $ 50,407   $ 6   $ 50,401    
Issuance of equity classified warrants to purchase common stock 1,228       1,228      
Foreign currency translation adjustment (1,786)             (1,786)
Reclassification of foreign currency translation to net income (loss), net of tax 894             894
Ending balance (in shares) at Jun. 27, 2026     515,793,219          
Ending balance at Jun. 27, 2026 $ 56,757   $ 52   $ 1,096,070   $ (1,034,585) $ (4,780)